Patrys Ltd (ASX:PAB) has begun manufacturing and regulatory activities for RLS-2201, its proprietary injectable quetiapine formulation being developed to treat delirium, as it works toward launching a ...

Patrys (ASX:PAB) has started key manufacturing and regulatory activities for the advancement of RLS-2201, the company’s proprietary injectable formulation of Quetiapine being developed to alleviate ...

Q1 2026 earnings call recap: record revenue, AI-driven demand, $7B backlog, and raised 2026 outlook & margins.

Attributed strong performance to market share gains in AI-driven connectivity, with 2026 expected to surpass 2025 as a peak ...

Ciena Corporation (NYSE:CIEN) Q1 2026 Earnings Call Transcript March 5, 2026 Ciena Corporation beats earnings expectations. Reported EPS is $1.35, expectations were $1.17. Operator: Good day, and ...

This note presents the key updates and revenue development highlights of the 2026 version of the IMF's World Revenue ...

At OFC 2026, taking place March 15-19 in Los Angeles, Ciena’s (NYSE: CIEN) booth (#1927) will feature innovations that redefine what’s possible in modern networking across data center networks, ...

Spaceflight entered a new era the moment a stainless-steel tower the size of a skyscraper lifted off the Texas coast. SpaceX ...

REalloys said the Defense Logistics Agency has awarded a contract to Terves LLC to scale next-generation production of ...

AI has designed candidate drugs for antibiotic-resistant infections and genetic diseases. But efforts to incorporate AI into the design of lipid nanoparticles (LNPs), the revolutionary delivery ...

The RiverPark Long/Short Opportunity Fund returned 0.13% in Q4 2025, with Alphabet and Eli Lilly as top contributors. Read ...